Key result
Elevated systemic inflammation (hsCRP ≥2 mg/L) in cancer survivors who received thoracic radiotherapy was associated with significantly lower resting left-ventricular ejection fraction (51% vs 61%).
Why the study?
Heart irradiation causes a dose-dependent risk of heart failure and animal studies show post-radiation cardiac inflammation, but whether inflammatory biomarkers correlate with changes in cardiac function and reserve after radiotherapy for breast or lung cancer remained unknown.
Cross-Sectional (n=25)
No
Absolute Event Rate: 51% vs 61%
p-value: p=0.039
Elevated systemic inflammation is associated with impaired left-ventricular systolic and diastolic function at rest and during exercise in patients who received thoracic radiotherapy for cancer.
May support closer LV monitoring in inflamed thoracic radiotherapy survivors; leaves open whether targeting inflammation preserves LVEF.
Background Irradiation of the heart during cancer radiotherapy is associated with a dose-dependent risk of heart failure. Animal studies have demonstrated that irradiation leads to an inflammatory response within the heart as well as a reduction in cardiac reserve. In the current study we aimed to evaluate whether inflammatory biomarkers correlated with changes in cardiac function and reserve after radiotherapy for breast or lung cancer. Methods and results We studied 25 subjects with a history of breast or lung cancer without a prior diagnosis of cardiovascular disease or heart failure, 1.8 years [0.4–3.6] post-radiotherapy involving at least 5 Gray (Gy) to at least 10% of the heart. High-sensitivity C-reactive protein (CRP) was abnormal (≥2 mg/L) in 16 (64%) subjects. Cardiac function and reserve was measured with Doppler echocardiography before and after exercise and defined as left-ventricular ejection fraction (LVEF), early diastolic mitral annulus velocity (e’), and increase in LV outflow tract velocity time integral cardiac output (cardiac reserve) with exercise. Subjects with abnormal CRP had significantly lower LVEF (51 [44–59] % vs 61 [52–64] %, P = 0.039), lower e’ (7.4 [6.6–7.9] cm/sec vs 9.9 [8.3–12.0] cm/sec, P = 0.010), and smaller cardiac reserve (+ 1.5 [1.2–1.7] L/min vs + 1.9 [1.7–2.2] L/min, P = 0.024). Conclusion Elevated systemic inflammation is associated with impaired left-ventricular systolic and diastolic function both at rest and during exercise in subjects who have received radiotherapy with significant incidental heart dose for the treatment of cancer.
No takes yet. Share an insight, caveat, or question.
Canada et al. (2020) conducted a cross-sectional in Thoracic radiotherapy-induced cardiomyopathy in breast or lung cancer survivors (n=25). Elevated high-sensitivity C-reactive protein (hsCRP ≥2.0 mg/L) vs. hsCRP <2.0 mg/L was evaluated on Left-ventricular ejection fraction (LVEF) (p=0.039). Elevated systemic inflammation (hsCRP ≥2 mg/L) in cancer survivors who received thoracic radiotherapy was associated with significantly lower resting left-ventricular ejection fraction (51% vs 61%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: